Oncology Drug Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Request Brochure Request Discount

Report Code: ZMR-2871 | Report Format : | Status : Upcoming |

Abstract

Oncology Drug Market: Overview

Oncology is a branch of therapeutic science that study malignancy and treatment and prevention of malignancy. Segments of oncology include radiation oncology (the use of radiation therapy to treat cancer), medical oncology (the use of chemotherapy, hormone therapy and other drugs to treat cancer), and surgical oncology (the use of surgeries to treat cancer).

Cancer is the uncontrolled growth of abnormal cells anywhere in an individual’s body. These cells are termed as tumor cells or malignant cells. Frequently, cancer cells can detach from this original mass of cells, travel along the blood and lymph systems, and lodge in other organs where they can repeat the uncontrolled growth cycle. This process of cancer cells, leaving an area and growing in another area of the body is termed as metastatic spread or metastasis.

Cancer stage is often determined by biopsy results which also helps to determine the cancer type and the extent to which cancer has spread in an individual. Staging also helps doctors to determine treatment protocols. 

Oncology Drug Market: Market Dynamics

Major drivers in the oncology drug market include growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, technological advancements in the healthcare sector, continuous patent expiry of key cancer drugs, rise in need for R&D activities in cancer, growing concerns over high death rates due to cancer and the rising impact of biosimilars.

The threat of failure and the adverse effects of cancer drug therapy; particularly chemotherapy, strict government regulations, the high cost of drug development is expected to hinder the growth of the global oncology drugs market over the forecast period.

Oncology treatments are rapidly evolving with the latest innovations emerging from immunotherapy research, thus creating new grounds for R&D for the competing firms, cancer vaccines is also seeing a genetic engineering of living immune cells and reinfusing them into cancer patients, re-emerged when combined with checkpoint inhibitors, yet another kind of immunotherapy, is swiftly advancing. The recent discovery of genes linked to ovarian cancer risk (RAD51C and RAD51D0), new pancreatic cancer susceptibility genes (CDKN2A, BRCA1/2, PALB2), and the discovery that many cases of pediatric cancer are associated with hereditary gene mutations, may lead to new kinds of targeted therapies.

Segmentation based on the Therapeutic Modals:

  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Hormonal therapy
  • Others

Segmentation based on the Cancer Type:

  • Breast cancer
  • Blood cancer
  • Prostate cancer

Gastrointestinal tract cancer

  • Skin cancer
  • Lung cancer
  • Others

Segmentation based on Regions:

North America dominates the oncology drug market over the forecast period, attributed to high presence of the cancer drugs development companies in the U.S. Additionally, high disposable incomes of consumers and compulsory health insurance cover for life-threatening diseases leads to increasing the affordability of cancer treatment in the U.S. Europe is the second largest revenue generating region in oncology drugs market over the forecast period.  The research for cancer drugs in developing economies including Asia Pacific, Latin America, and the Middle East and Africa is emerging with the focus towards the development of biosimilars. The prevalence of various cancer types is high in developing countries which generates interest for these regions to conduct clinical trials. In addition, the cost of research is low in these regions due to favorable government policies and the availability of a huge population base contributing to the oncology drug market growth in the developing countries. This, in turn, results in the significant growth of oncology drug market in the developing region over the forecast period.

Oncology Drug Market: Competitors

Some of the key players in the global oncology drug market include Johnson & Johnson, Amgen Inc., Eli lilly & Co., GlaxoSmithKline, Roche diagnostics, Merck & Co., Pfizer, Sanofi, and Celgene Corporation, and Novartis AG.

Global Heat Stabilizer Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Macrolide Drugs Market by Drug Type (14-membered ring agents, 14-membered ring agents, 15-membered ring agents (Azalides), 16-membered ring agents, and Ketolides), By Distribution Channels (Hospital pharmacies, Clinics, Hospitals, Retail pharmacies, and Online pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3230 | Report Format:

The report covers forecast and analysis for the macrolide drugs market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the macrolide drugs market along...Read More

Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, and Others), By Drug Type (mAb, Immunomodulators, Hematopoietic Agents, G-CSF, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3228 | Report Format:

The report covers forecast and analysis for the oncology biosimilar market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the oncology biosimilar...Read More

Automation and Control System Market in Pharmaceutical and Biotech Industry: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3900.00 | Report Code: ZMR-3213 | Report Format:

Global Automation and Control System Market: Overview Automation basically means the use of various control systems for operating equipments like machinery, processes in factories, boilers and heat treating ovens, stabilization of ships, aircrafts and other applications and vehicles with minimal...Read More

Myelofibrosis Treatment Market by Diagnosis Type (Gene Mutation Analysis, Bone Marrow biopsy, Imaging Test, and Blood Tests), by Treatment Type (Chemotherapy, Blood Transfusions, Stem Cell Transplant, Splenectomy, Radiation Therapy, and Others), by Drug Type (Hydroxyurea, Immunomodulators, JAK Inhibitor, and Others), and by End-User (Hospitals, Clinics, and Bone Marrow Transplant Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3210 | Report Format:

The report covers forecast and analysis for the myelofibrosis treatment market on the global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the myelofibrosi...Read More

Hemophilia Treatment Drugs Market by Product Type (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Desmopressin, and Antifibrinolytic Agents), by Disease Type (Hemophilia A, Hemophilia B, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3187 | Report Format:

The report covers forecast and analysis for the hemophilia treatment drugs market on a global and regional level. The study provides historical data from 2015 to 2017 along with the forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the hemophi...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.